Alhavi Company (DEHAVI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DEHAVI
- Industry
- Pharmaceuticals
- Market
- IFB Base Market
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 23,007,896 | 8,087,561 | 3,386,675 | 4,608,563 | 3,561,839 | 1,589,424 |
| Cost of operating revenue | -11,513,246 | -5,401,892 | -2,396,856 | -2,393,213 | -2,150,607 | -1,072,334 |
| Gross profit (loss) | 11,494,650 | 2,685,669 | 989,819 | 2,215,350 | 1,411,232 | 517,090 |
| Selling, general and administrative expenses | -1,832,676 | -1,203,988 | -589,369 | -686,811 | -443,748 | -272,275 |
| Other income | 353,991 | 179,128 | 63,600 | 172,543 | 56,616 | 1,602 |
| Other expenses | -100,166 | 0 | 0 | -1,811 | 0 | -227 |
| Operating profit (loss) | 9,915,799 | 1,660,809 | 464,050 | 1,699,271 | 1,024,100 | 246,190 |
| Finance costs | -707,049 | -56,864 | -164,945 | -162,012 | -78,956 | -43,022 |
| Other non-operating income and expenses | 82,149 | 54,979 | 17,538 | -28,499 | 12,265 | 7,376 |
| Profit (loss) from continuing operations before tax | 9,290,899 | 1,658,924 | 316,643 | 1,508,760 | 957,409 | 210,544 |
| Current year tax | -2,301,081 | -404,730 | -77,331 | -375,302 | -238,335 | -51,282 |
| Net profit (loss) from continuing operations | 6,989,818 | 1,254,194 | 173,958 | 1,099,828 | 719,074 | 159,262 |
| Net profit (loss) | 6,989,818 | 1,254,194 | 173,958 | 1,099,828 | 719,074 | 159,262 |
| Basic earnings (loss) per share | 1,079 rials | 193 rials | 27 rials | 1,018 rials | 666 rials | 147 rials |
| Net earnings (loss) per share, rials | 1,079 rials | 194 rials | 27 rials | 1,019 rials | 666 rials | 0 rials |
| Capital | 6,480,000 | 6,480,000 | 6,480,000 | 1,080,000 | 1,080,000 | 1,080,000 |
Reporting periods
74 periods are on file for this report, from the period ending 1388/12/29 to the period ending 1405/06/31.